Lv Huibin, Teo Qi Wen, Lee Chang-Chun D, Liang Weiwen, Choi Danbi, Mao Kevin J, Ardagh Madison R, Gopal Akshita B, Mehta Arjun, Szlembarski Matt, Bruzzone Roberto, Wilson Ian A, Wu Nicholas C, Mok Chris K P
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
J Virol. 2025 Jan 31;99(1):e0169524. doi: 10.1128/jvi.01695-24. Epub 2024 Dec 5.
Understanding how immune history influences influenza immunity is essential for developing effective vaccines and therapeutic strategies. This study examines the antigenic imprinting of influenza hemagglutinin (HA) and neuraminidase (NA) using a mouse model with sequential infections by H1N1 virus strains exhibiting substantial antigenic differences in HA. In our pre-2009 influenza infection model, we observed that mice with more extensive infection histories produced higher levels of functional NA-inhibiting antibodies (NAI). However, following further infection with the 2009 pandemic H1N1 strain, these mice demonstrated a reduced NAI to the challenged virus. Interestingly, prior exposure to older strains resulted in a lower HA antibody response (neutralization and HAI) to the challenged virus in both pre- and post-2009 scenarios, potentially due to faster viral clearance facilitated by immune memory recall. Overall, our findings reveal distinct trajectories in HA and NA immune responses, suggesting that immune imprinting can differentially impact these proteins based on the extent of antigenic variation in influenza viruses.
Influenza viruses continue to pose a significant threat to human health, with vaccine effectiveness remaining a persistent challenge. Individual immune history is a crucial factor that can influence antibody responses to subsequent influenza exposures. While many studies have explored how pre-existing antibodies shape the induction of anti-HA antibodies following influenza virus infections or vaccinations, the impact on anti-NA antibodies has been less extensively studied. Using a mouse model, our study demonstrates that within pre-2009 H1N1 strains, an extensive immune history negatively impacted anti-HA antibody responses but enhanced anti-NA antibody responses. However, in response to the 2009 pandemic H1N1 strain, which experienced an antigenic shift, both anti-HA and anti-NA antibody responses were hindered by antibodies from prior pre-2009 H1N1 virus infections. These findings provide important insights into how antigenic imprinting affects both anti-HA and anti-NA antibody responses and underscore the need to consider immune history in developing more effective influenza vaccination strategies.
了解免疫史如何影响流感免疫力对于开发有效的疫苗和治疗策略至关重要。本研究使用小鼠模型,通过对甲型流感病毒H1N1毒株进行连续感染,该毒株在血凝素(HA)上表现出显著的抗原差异,以此来研究流感血凝素(HA)和神经氨酸酶(NA)的抗原印记。在我们2009年之前的流感感染模型中,我们观察到感染史更广泛的小鼠产生了更高水平的具有功能的抑制神经氨酸酶抗体(NAI)。然而,在用2009年大流行的甲型H1N1毒株进一步感染后,这些小鼠对受攻击病毒的NAI降低。有趣的是,在2009年之前和之后的情况下,先前接触较旧毒株均导致对受攻击病毒的HA抗体反应(中和及血凝抑制)较低,这可能是由于免疫记忆回忆促进了病毒更快清除。总体而言,我们的研究结果揭示了HA和NA免疫反应的不同轨迹,表明免疫印记可根据流感病毒抗原变异程度对这些蛋白质产生不同影响。
流感病毒继续对人类健康构成重大威胁,疫苗有效性仍然是一个持续的挑战。个体免疫史是影响对后续流感暴露抗体反应的关键因素。虽然许多研究探讨了既往抗体如何影响流感病毒感染或疫苗接种后抗HA抗体的诱导,但对抗NA抗体的影响研究较少。使用小鼠模型,我们的研究表明,在2009年之前的甲型H1N1毒株中,广泛的免疫史对抗HA抗体反应有负面影响,但增强了抗NA抗体反应。然而,对于经历了抗原转变的2009年大流行甲型H1N1毒株,2009年之前甲型H1N1病毒感染产生的抗体阻碍了抗HA和抗NA抗体反应。这些发现为抗原印记如何影响抗HA和抗NA抗体反应提供了重要见解,并强调在制定更有效的流感疫苗接种策略时需要考虑免疫史。